Breast Neoplasms
Showing NaN - NaN of 38
Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))
Completed
- Breast Neoplasms
- KU-0059436 (AZD2281) (PARP inhibitor)
-
West Hollywood, California
- +16 more
Jan 24, 2023
Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)
Active, not recruiting
- Breast Neoplasms
- PD-0332991
- +2 more
-
Bellflower, California
- +304 more
Dec 6, 2022
Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)
Active, not recruiting
- Breast Neoplasms
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +141 more
Nov 15, 2022
Breast Tumors Trial in Worldwide (pembrolizumab, paclitaxel, nab-paclitaxel)
Recruiting
- Breast Neoplasms
- pembrolizumab
- +6 more
-
Tucson, Arizona
- +188 more
Aug 11, 2022
Breast Tumors, Radiotherapy, Lymphedema Trial in Canada (Locoregional radiation treatment - Conventional fractionation,
Recruiting
- Breast Neoplasms
- +2 more
- Locoregional radiation treatment - Conventional fractionation
- Locoregional radiation treatment - Hypofractionation
-
Calgary, Alberta, Canada
- +12 more
May 26, 2022
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib, Physician's-Choice)
Completed
- Breast Neoplasms
- +2 more
-
Flagstaff, Arizona
- +361 more
Dec 20, 2021
Concordance Between Liquid and Tissue Biopsy
Recruiting
- Breast Neoplasms
- Blood Draw
-
London, Ontario, CanadaLondon Regional Cancer Program
Aug 31, 2021
Breast Tumors Trial in London, Ottawa, Thunder Bay (TC-H x Paclitaxel (P) + Trastuzumab(T))
Active, not recruiting
- Breast Neoplasms
- TC-H x Paclitaxel (P) + Trastuzumab(T)
-
London, Ontario, Canada
- +2 more
Jun 8, 2021
Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Background hormonal therapy)
Terminated
- Breast Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +2 more
-
Bakersfield, California
- +70 more
Jul 29, 2020
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib)
Terminated
- Breast Neoplasms
- +2 more
-
Greenbrae, California
- +70 more
Oct 10, 2019
Breast Tumors Trial in Worldwide (Vinorelbine 25 mg/m2 weekly, Afatinib 40mg once daily (OD), Paclitaxel 80 mg/m2 weekly)
Completed
- Breast Neoplasms
- Vinorelbine 25 mg/m2 weekly
- +2 more
-
Hong Kong, Hong Kong
- +26 more
Mar 15, 2019
Breast Tumors, Breast Diseases Trial in United Kingdom (Breast reconstruction - implant and an ADM (SurgiMend), Breast
Unknown status
- Breast Neoplasms
- Breast Diseases
- Breast reconstruction - implant and an ADM (SurgiMend)
- +2 more
-
Winchester, Hampshire, United Kingdom
- +5 more
Mar 12, 2018
Quality of Life of People With HER2 Positive Breast Cancer
Completed
- Breast Neoplasms
- No Intervention
-
Abergavenny, United Kingdom
- +13 more
Mar 31, 2017
PICTURE Breast L: Patient Information Combined for Local Therapy
Completed
- Breast Neoplasms
-
Leiden, Netherlands
- +2 more
Mar 16, 2017
Breast Tumors Trial in London (EnLight, LightPath)
Unknown status
- Breast Neoplasms
- EnLight
- LightPath
-
London, United KingdomGuy's Hospital
Sep 6, 2016
Breast Tumors, Anesthesia Trial in London (Single injection paravertebral block, Multiple injection paravertebral blocks)
Completed
- Breast Neoplasms
- Anesthesia
- Single injection paravertebral block
- Multiple injection paravertebral blocks
-
London, Ontario, Canada
- +1 more
Aug 15, 2016
Breast Tumors Trial in Worldwide (Afatinib once daily (OD), Vinorelbine Weekly)
Completed
- Breast Neoplasms
- Afatinib once daily (OD)
- Vinorelbine Weekly
-
Los Angeles, California
- +15 more
Jun 17, 2016